PEGS Boston Virtual Summit
Presentation Title: Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models
Time: 9:45 AM – 10:10 AM EDT on Monday, August 31
Programs: Antibody for Cancer Therapy
Speaker: Qingcong Lin, PhD, CEO, Biocytogen Boston Corp.
With a robust immune response, RenMab™ Mouse produces fully-human antibodies with high specificity and diverse epitope coverage. To identify leads, Biocytogen has created a catalog of target-humanized mouse models, allowing to conduct high throughput in vivo hit screening. Lastly, to further select for drug candidates with best clinical translation potential, Biocytogen offers immune-cell humanized mouse models for preclinical pharmacology evaluation. Biocytogen integrates these three mouse models to catalyze the process from target validation to IND application.
About PEGS Boston
PEGS Boston Virtual Summit aims to bring you a dynamic online learning and networking experience. Discover research at the forefront of biotherapeutics development and breakthroughs, hear inspiring keynote presentations, interact with global participants, join live Q&A panels and breakout discussions, visit our online exhibit hall and chat with service providers and poster presenters, and receive an on-demand library of presentations.